Reuters logo
BRIEF-Shanghai Fosun Pharma to buy stake in Taiwan's Henlix Biotech for up to $98 mln
November 2, 2017 / 8:55 AM / 21 days ago

BRIEF-Shanghai Fosun Pharma to buy stake in Taiwan's Henlix Biotech for up to $98 mln

Nov 2 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd

* Says it plans to buy about 69.3 percent stake in Taiwan’s Henlix Biotech Inc for up to $98 million

Source text in Chinese: bit.ly/2A6rqvj

Further company coverage: (Reporting by Hong Kong newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below